Case management of the anemic patient. Epoetin alfa: focus on reimbursement.

Abstract

Epoetin alfa therapy has been proven effective in treating anemia in dialysis patients; it increases the hematocrit (HCT) and improves the quality of life. The reimbursement policy for Epoetin alfa therapy is very important to dialysis patients; nurses need to understand the policy to help patients with reimbursement and to comply with the provisions for patient monitoring and education.

• Authors: W I Roe
• Journal: ANNA journal (ANNA J) Vol. 19 Issue 2 Pg. 198-9 (Apr 1992) ISSN: 8750-0779 [Print] United States
• PMID: 1586234 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Erythropoietin

Topics

• Anemia (drug therapy, etiology, nursing)
• Erythropoietin (administration & dosage, therapeutic use)
• Humans
• Kidney Failure, Chronic (complications, economics)
• Male
• Middle Aged
• Reimbursement Mechanisms
• Self Administration